Antimicrobial resistance (AMR) threatens the foundation of modern medicine and is described by the World Health Organization as one of the top global public health and development threats. It occurs when bacteria and other disease-causing microbes gain the ability to resist the action of treatments designed to kill them.
AMR has led to at least one million deaths each year since 1990 and is expected to cause another 39 million deaths between now and 2050. AMR is directly related to 16 of the 17 UN Sustainable Development Goals, with severe negative implications for poverty, gender inequality, animal welfare, the environment, and food security.
In response to this far-reaching threat, the newly established Oxford AMR Network harnesses the University of Oxford’s considerable expertise in life sciences, medical and social sciences, and humanities to tackle this challenge through multiple approaches.
There are over 200 researchers working to tackle AMR across Oxford. Their work spans new drug discovery and antibiotic stewardship, to development of diagnostic tools and AMR surveillance and epidemiology.
Funded and hosted by the Ineos Oxford Institute for antimicrobial research (IOI), the network will mobilise Oxford University’s expertise in AMR to facilitate new collaborations and generate novel research to find solutions. A new database will list researchers across the university whose wide-ranging expertise exemplifies the vast array of world-leading research from Oxford teams, including overseas units in the MORU Tropical Health Network and the Oxford University Clinical Research Unit OUCRU).
more recommended stories
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance — University of Oxford, Medical Sciences DivisionThe IOI Synergy Grants scheme is.
The Translational Research Immunology Group (TRIG) celebrates huge success at International Congress of The Transplantation SocietyNora Atallah and Professor Fadi Issa.
Leave a Comment